Attachment: Extract from Clinical Evaluation Influenza ...

This is a submission by the sponsor to register Influvac Tetra for the prevention of influenza A and B in adults aged ≥ 18 years. The suspension for injection includes 4 inactivated, split influenza virus strains (15/15/15/15 µg (total 60 µg) per 0.5 mL), 2 type A strain subtypes and 2 type B strains from separate lineages as recommended by the Australian Influenza Vaccine … ................
................